SEC Form 4/A · accession 0001610717-26-000330
Omada Health, Inc. · OMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steven L. Cook
Officer — Chief Financial Officer
Period of report
Jun 26, 2026
Accepted (ET)
Jul 8, 2026 · 8:17 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001611115
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2026 | M | 13,573 | $8.28 | A | 200,782 | D | |
| Common Stock | Jun 26, 2026 | M | 19,427 | $8.01 | A | 220,209 | D | |
| Common StockF3,F1 | Jun 26, 2026 | S | 33,000 | $19.8924 | D | 187,209 | D | |
| Common Stock | Jun 29, 2026 | M | 17,950 | $8.28 | A | 205,159 | D | |
| Common StockF1 | Jun 29, 2026 | S | 17,950 | $21.0678 | D | 187,209 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $8.28 | Jun 26, 2026 | M | 13,573 | D | — | Jul 19, 2031 | Common Stock | 13,573 | 319,759 | D |
| Stock Option (Right to Buy)F5 | $8.01 | Jun 26, 2026 | M | 19,427 | D | — | Feb 8, 2034 | Common Stock | 19,427 | 20,834 | D |
| Stock Option (Right to Buy)F4 | $8.28 | Jun 29, 2026 | M | 17,950 | D | — | Jul 19, 2031 | Common Stock | 17,950 | 301,809 | D |
Explanation of responses
- F1This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- F2Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- F3This transaction was executed in multiple trades at prices ranging from $19.6727 to $20.078. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4100% of the shares subject to the option are fully vested and exercisable.
- F51/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.